Adriano Gravina
Via M. Semmola 52
Naples, 80131, Italy
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments.
Journal: Journal of translational medicine
Published: February 11, 2025
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
Journal: JAMA network open
Published: November 02, 2023
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2022
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: August 16, 2022
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Journal: Journal of translational medicine
Published: October 22, 2021
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.
Journal: Life (Basel, Switzerland)
Published: October 12, 2021
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
Journal: Future oncology (London, England)
Published: August 24, 2021
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
Journal: BMC cancer
Published: February 20, 2021
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Journal: Journal of translational medicine
Published: September 28, 2020
Denosumab in early breast cancer: negative data and a call to action.
Journal: The Lancet. Oncology
Published: October 16, 2019
Last Updated: 09/26/2026